| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 6.41e-07 | 27 | 125 | 5 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 7.77e-07 | 28 | 125 | 5 | GO:0099602 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | VRK2 CDK12 ROR1 ADCK1 INSR PAPSS2 PTK7 CHUK MAPK14 CSNK2B GUCY2D PIP4K2A PIP4K2B PEAK1 STKLD1 | 3.76e-05 | 709 | 125 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | VRK2 CDK12 ROR1 ADCK1 INSR PTDSS2 PAPSS2 PTK7 CHUK MAPK14 CSNK2B GUCY2D PIP4K2A PIP4K2B PEAK1 STKLD1 POLQ | 7.69e-05 | 938 | 125 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | VRK2 CDK12 ROR1 ADCK1 INSR PAPSS2 PTK7 CHUK MAPK14 CSNK2B GUCY2D PIP4K2A PIP4K2B PEAK1 STKLD1 | 8.73e-05 | 764 | 125 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-phosphate 4-kinase activity | 1.16e-04 | 3 | 125 | 2 | GO:0016309 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNH7 TMC2 TRPA1 TRPC5 OCA2 RYR2 TPCN1 SLC9C1 CLCN7 CLCA2 ATP5F1B | 1.48e-04 | 459 | 125 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.53e-04 | 17 | 125 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.82e-04 | 18 | 125 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein kinase activity | VRK2 CDK12 ROR1 ADCK1 INSR PTK7 CHUK MAPK14 CSNK2B GUCY2D PEAK1 STKLD1 | 3.90e-04 | 600 | 125 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | channel activity | KCNH7 TMC2 TRPA1 TRPC5 OCA2 RYR2 TPCN1 SLC9C1 CLCN7 CLCA2 ATP5F1B | 4.66e-04 | 525 | 125 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | KCNH7 TMC2 TRPA1 TRPC5 OCA2 RYR2 TPCN1 SLC9C1 CLCN7 CLCA2 ATP5F1B | 4.74e-04 | 526 | 125 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.47e-04 | 31 | 125 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.08e-03 | 72 | 125 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.14e-03 | 33 | 125 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 1.24e-03 | 34 | 125 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.32e-03 | 129 | 125 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 1.36e-03 | 9 | 125 | 2 | GO:0016308 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.84e-03 | 441 | 125 | 9 | GO:0016887 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 3.22e-07 | 25 | 122 | 5 | GO:0045737 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 5.88e-07 | 28 | 122 | 5 | GO:1904031 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | NPR3 MYO9B ROR1 INSR WRN EPB41L5 GMIP RYR2 CHUK MAPK14 NRXN1 TCL1A TMEM132A SPDYE2 TBC1D12 UHRF1 LRP6 LRP5 SPDYE5 SPDYE2B SPDYE6 ARAP1 WDR24 SPDYE16 | 2.88e-06 | 1430 | 122 | 24 | GO:0044093 |
| GeneOntologyBiologicalProcess | mesodermal cell migration | 1.65e-05 | 9 | 122 | 3 | GO:0008078 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | NPR3 MYO9B ROR1 INSR WRN GMIP MAPK14 NRXN1 TCL1A SPDYE2 TBC1D12 UHRF1 SPDYE5 SPDYE2B SPDYE6 ARAP1 WDR24 SPDYE16 | 3.43e-05 | 1028 | 122 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | CDK12 INSR NRXN1 SPDYE2 LRP6 LRP5 SPDYE5 SPDYE2B SPDYE6 SPDYE16 | 5.39e-05 | 358 | 122 | 10 | GO:0071900 |
| GeneOntologyBiologicalProcess | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process | 1.04e-04 | 3 | 122 | 2 | GO:1902635 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | ROR1 INSR NRXN1 TCL1A SPDYE2 SPDYE5 SPDYE2B SPDYE6 WDR24 SPDYE16 | 1.49e-04 | 405 | 122 | 10 | GO:0033674 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 1.52e-04 | 193 | 122 | 7 | GO:0071902 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.64e-04 | 261 | 122 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.85e-04 | 48 | 122 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process | 2.07e-04 | 4 | 122 | 2 | GO:1902633 | |
| GeneOntologyBiologicalProcess | cell migration involved in gastrulation | 2.14e-04 | 20 | 122 | 3 | GO:0042074 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | CDK12 ROR1 INSR NRXN1 TCL1A SPDYE2 LRP6 LRP5 SPDYE5 SPDYE2B SPDYE6 WDR24 SPDYE16 | 2.14e-04 | 686 | 122 | 13 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 2.39e-04 | 350 | 122 | 9 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.65e-04 | 96 | 122 | 5 | GO:0000079 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | CDK12 INSR NRXN1 TCL1A SPDYE2 LRP6 LRP5 SPDYE5 SPDYE2B SPDYE6 WDR24 SPDYE16 | 2.74e-04 | 611 | 122 | 12 | GO:0045859 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 3.21e-04 | 100 | 122 | 5 | GO:1904029 | |
| GeneOntologyBiologicalProcess | Norrin signaling pathway | 3.43e-04 | 5 | 122 | 2 | GO:0110135 | |
| Domain | Spy1 | 3.58e-11 | 11 | 125 | 6 | PF11357 | |
| Domain | Speedy | 3.58e-11 | 11 | 125 | 6 | IPR020984 | |
| Domain | Rho_GTPase_activation_prot | 2.76e-05 | 88 | 125 | 6 | IPR008936 | |
| Domain | LRP5/6 | 4.44e-05 | 2 | 125 | 2 | IPR017049 | |
| Domain | Ion_trans_dom | 1.18e-04 | 114 | 125 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.18e-04 | 114 | 125 | 6 | PF00520 | |
| Domain | - | 1.33e-04 | 3 | 125 | 2 | 4.10.1130.10 | |
| Domain | - | 1.54e-04 | 16 | 125 | 3 | 1.10.506.10 | |
| Domain | RasGAP_dom | 2.22e-04 | 18 | 125 | 3 | IPR001936 | |
| Domain | Kinase-like_dom | VRK2 CDK12 ROR1 ADCK1 INSR PTK7 CHUK MAPK14 DST GUCY2D PEAK1 STKLD1 | 2.84e-04 | 542 | 125 | 12 | IPR011009 |
| Domain | Prot_kinase_dom | VRK2 CDK12 ROR1 ADCK1 INSR PTK7 CHUK MAPK14 GUCY2D PEAK1 STKLD1 | 4.49e-04 | 489 | 125 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | VRK2 CDK12 ROR1 ADCK1 INSR PTK7 CHUK MAPK14 GUCY2D PEAK1 STKLD1 | 4.80e-04 | 493 | 125 | 11 | PS50011 |
| Domain | EF-hand-dom_pair | 7.03e-04 | 287 | 125 | 8 | IPR011992 | |
| Domain | PInositol-4-P-5-kinase | 9.13e-04 | 7 | 125 | 2 | IPR023610 | |
| Domain | PIPKc | 1.21e-03 | 8 | 125 | 2 | SM00330 | |
| Domain | - | 1.21e-03 | 8 | 125 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 1.21e-03 | 8 | 125 | 2 | PF01504 | |
| Domain | PIPK | 1.21e-03 | 8 | 125 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 1.21e-03 | 8 | 125 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 1.21e-03 | 8 | 125 | 2 | IPR027483 | |
| Domain | - | 1.21e-03 | 8 | 125 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 1.21e-03 | 8 | 125 | 2 | IPR002498 | |
| Domain | BTK | 1.55e-03 | 9 | 125 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 1.55e-03 | 9 | 125 | 2 | IPR001562 | |
| Domain | BTK | 1.55e-03 | 9 | 125 | 2 | PF00779 | |
| Domain | ZF_BTK | 1.55e-03 | 9 | 125 | 2 | PS51113 | |
| Domain | - | 1.89e-03 | 261 | 125 | 7 | 1.10.238.10 | |
| Domain | RECEPTOR_TYR_KIN_II | 2.81e-03 | 12 | 125 | 2 | PS00239 | |
| Domain | PROTEIN_KINASE_ATP | 3.75e-03 | 459 | 125 | 9 | PS00107 | |
| Domain | RasGAP | 3.84e-03 | 14 | 125 | 2 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.84e-03 | 14 | 125 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.84e-03 | 14 | 125 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.84e-03 | 14 | 125 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.84e-03 | 14 | 125 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | MT | 3.84e-03 | 14 | 125 | 2 | PF12777 | |
| Domain | AAA_8 | 3.84e-03 | 14 | 125 | 2 | PF12780 | |
| Domain | Ldl_recept_b | 3.84e-03 | 14 | 125 | 2 | PF00058 | |
| Domain | LDLRB | 3.84e-03 | 14 | 125 | 2 | PS51120 | |
| Domain | RasGAP_CS | 3.84e-03 | 14 | 125 | 2 | IPR023152 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | PROTEIN_KINASE_TYR | 4.10e-03 | 97 | 125 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.10e-03 | 97 | 125 | 4 | IPR008266 | |
| Domain | - | MTG1 DYNC2H1 WRN SRCAP NKIRAS1 PAPSS2 NWD2 DHX35 ATL2 POLQ DNAH6 ATP5F1B | 4.31e-03 | 746 | 125 | 12 | 3.40.50.300 |
| Domain | DHC_fam | 4.41e-03 | 15 | 125 | 2 | IPR026983 | |
| Domain | RasGAP | 4.41e-03 | 15 | 125 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.41e-03 | 15 | 125 | 2 | PS00509 | |
| Domain | Dynein_heavy | 4.41e-03 | 15 | 125 | 2 | PF03028 | |
| Domain | LY | 4.41e-03 | 15 | 125 | 2 | SM00135 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.41e-03 | 15 | 125 | 2 | PS50018 | |
| Domain | Dynein_heavy_dom | 4.41e-03 | 15 | 125 | 2 | IPR004273 | |
| Domain | LDLR_classB_rpt | 4.41e-03 | 15 | 125 | 2 | IPR000033 | |
| Domain | P-loop_NTPase | MTG1 DYNC2H1 MYO9B WRN SRCAP NKIRAS1 PAPSS2 NWD2 DHX35 ATL2 POLQ DNAH6 ATP5F1B | 4.48e-03 | 848 | 125 | 13 | IPR027417 |
| Domain | EF_HAND_2 | 4.64e-03 | 231 | 125 | 6 | PS50222 | |
| Domain | Kringle_CS | 5.66e-03 | 17 | 125 | 2 | IPR018056 | |
| Domain | KRINGLE_1 | 5.66e-03 | 17 | 125 | 2 | PS00021 | |
| Domain | KR | 5.66e-03 | 17 | 125 | 2 | SM00130 | |
| Domain | Kringle | 5.66e-03 | 17 | 125 | 2 | IPR000001 | |
| Domain | KRINGLE_2 | 5.66e-03 | 17 | 125 | 2 | PS50070 | |
| Domain | Kringle | 5.66e-03 | 17 | 125 | 2 | PF00051 | |
| Domain | Helicase_C | 5.81e-03 | 107 | 125 | 4 | PF00271 | |
| Domain | HELICc | 5.81e-03 | 107 | 125 | 4 | SM00490 | |
| Domain | Helicase_C | 6.00e-03 | 108 | 125 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 6.20e-03 | 109 | 125 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.20e-03 | 109 | 125 | 4 | PS51192 | |
| Domain | DEXDc | 6.20e-03 | 109 | 125 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.40e-03 | 110 | 125 | 4 | IPR014001 | |
| Domain | C1_1 | 6.58e-03 | 57 | 125 | 3 | PF00130 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.67e-06 | 106 | 86 | 7 | M27200 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 1.20e-05 | 8 | 86 | 3 | MM14976 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.55e-05 | 183 | 86 | 8 | M997 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.08e-05 | 99 | 86 | 6 | MM14910 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 4.78e-05 | 157 | 86 | 7 | MM15226 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 5.39e-05 | 160 | 86 | 7 | M27498 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 9.46e-05 | 15 | 86 | 3 | M27273 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.83e-05 | 176 | 86 | 7 | MM15718 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 2.09e-04 | 89 | 86 | 5 | M39563 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 2.44e-04 | 92 | 86 | 5 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 2.44e-04 | 92 | 86 | 5 | M27636 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 3.27e-04 | 98 | 86 | 5 | M39731 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 3.64e-04 | 5 | 86 | 2 | M48304 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 5.27e-04 | 304 | 86 | 8 | MM14960 | |
| Pathway | REACTOME_SIGNALING_BY_LRP5_MUTANTS | 5.43e-04 | 6 | 86 | 2 | M27432 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 6.29e-04 | 113 | 86 | 5 | M39669 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 6.43e-04 | 28 | 86 | 3 | M77 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 7.77e-11 | 9 | 128 | 5 | 36272447 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 7.84e-10 | 13 | 128 | 5 | 15611625 | |
| Pubmed | EFCAB5 FAM114A1 DTNA SPTAN1 HEATR1 SRCAP EPX RYR2 PPP4R4 PTK7 CHUK IVD DST NRXN1 SACS FAM186A PIP4K2A RPF2 PIP4K2B ATP11A POLQ DNAH6 ATP5F1B | 2.86e-09 | 1442 | 128 | 23 | 35575683 | |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 3.73e-09 | 17 | 128 | 5 | 15574121 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 18502762 | ||
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 20846389 | ||
| Pubmed | Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6. | 1.34e-05 | 2 | 128 | 2 | 21887268 | |
| Pubmed | PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors. | 1.34e-05 | 2 | 128 | 2 | 33136328 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28938444 | ||
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 1.34e-05 | 2 | 128 | 2 | 11448776 | |
| Pubmed | LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. | 1.34e-05 | 2 | 128 | 2 | 15084453 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15578697 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33164872 | ||
| Pubmed | LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis. | 1.34e-05 | 2 | 128 | 2 | 25902418 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30474181 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 36552732 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25783012 | ||
| Pubmed | Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. | 1.34e-05 | 2 | 128 | 2 | 19147944 | |
| Pubmed | Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. | 1.34e-05 | 2 | 128 | 2 | 15537447 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17335347 | ||
| Pubmed | The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. | 1.34e-05 | 2 | 128 | 2 | 19503830 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29727621 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 37202775 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20926594 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16355283 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28425175 | ||
| Pubmed | Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. | 1.34e-05 | 2 | 128 | 2 | 18350154 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33118644 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18493104 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30668923 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22433869 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18639560 | ||
| Pubmed | Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. | 1.34e-05 | 2 | 128 | 2 | 25802278 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28659173 | ||
| Pubmed | Distinct roles of LRP5 and LRP6 in Wnt signaling regulation in the retina. | 1.34e-05 | 2 | 128 | 2 | 33545636 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16041389 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12579474 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22307324 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | XRN2 MYO9B INSR HEATR1 SRCAP PLXNB2 BLMH DST SACS BBS7 CSNK2B RPF2 UHRF1 ATP5F1B | 2.61e-05 | 1024 | 128 | 14 | 24711643 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | EFCAB5 KREMEN1 MYO9B CDK12 HEATR1 SPDYE18 CLCA2 CSHL1 SPDYE2 FHIP1A | 3.98e-05 | 552 | 128 | 10 | 10737800 |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 30718367 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22763696 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 24412065 | ||
| Pubmed | Structural insight into the mechanisms of Wnt signaling antagonism by Dkk. | 4.02e-05 | 3 | 128 | 2 | 18524778 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25710911 | ||
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 4.02e-05 | 3 | 128 | 2 | 25637021 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27803037 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25495341 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18704119 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18406176 | ||
| Pubmed | Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases. | 4.02e-05 | 3 | 128 | 2 | 32619402 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23758345 | ||
| Pubmed | Lrp5 and Lrp6 play compensatory roles in mouse intestinal development. | 4.02e-05 | 3 | 128 | 2 | 21866564 | |
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 4.02e-05 | 3 | 128 | 2 | 31197031 | |
| Pubmed | The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis. | 4.02e-05 | 3 | 128 | 2 | 26774281 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 29602775 | ||
| Pubmed | LRP5 in premature adrenarche and in metabolic characteristics of prepubertal children. | 4.02e-05 | 3 | 128 | 2 | 18721193 | |
| Pubmed | tPA regulates neurite outgrowth by phosphorylation of LRP5/6 in neural progenitor cells. | 4.02e-05 | 3 | 128 | 2 | 23925701 | |
| Pubmed | The structural basis of DKK-mediated inhibition of Wnt/LRP signaling. | 4.02e-05 | 3 | 128 | 2 | 22589387 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25959626 | ||
| Pubmed | Two structural and functional domains of MESD required for proper folding and trafficking of LRP5/6. | 4.02e-05 | 3 | 128 | 2 | 21397183 | |
| Pubmed | Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6. | 4.02e-05 | 3 | 128 | 2 | 22000856 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 24743782 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33650028 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 24209622 | ||
| Pubmed | Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. | 4.02e-05 | 3 | 128 | 2 | 30664649 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22576936 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 34001596 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25009587 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27524201 | ||
| Pubmed | TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation. | 4.02e-05 | 3 | 128 | 2 | 33065966 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DTNA ROR1 EPB41L5 CDCP1 PTK7 BLMH CLCN7 ATP11A PEAK1 SLITRK6 | 5.13e-05 | 569 | 128 | 10 | 30639242 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO9B CDK12 SRCAP PLXNB2 TPCN1 DST CLCN7 BTBD7 TMEM132A LRP5 PDZD8 HAS3 ARAP1 WDR24 | 5.93e-05 | 1105 | 128 | 14 | 35748872 |
| Pubmed | 6.12e-05 | 467 | 128 | 9 | 30194290 | ||
| Pubmed | LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. | 7.12e-05 | 22 | 128 | 3 | 25982273 | |
| Pubmed | A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. | 8.02e-05 | 4 | 128 | 2 | 9367159 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 26772978 | ||
| Pubmed | PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay. | 8.02e-05 | 4 | 128 | 2 | 33984270 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 23041840 | ||
| Pubmed | Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts. | 8.02e-05 | 4 | 128 | 2 | 29176883 | |
| Pubmed | SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. | 8.02e-05 | 4 | 128 | 2 | 15908424 | |
| Pubmed | Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. | 8.02e-05 | 4 | 128 | 2 | 23675479 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 31452509 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 32729832 | ||
| Pubmed | Critical Endothelial Regulation by LRP5 during Retinal Vascular Development. | 8.02e-05 | 4 | 128 | 2 | 27031698 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 16234249 | ||
| Pubmed | PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism. | 8.02e-05 | 4 | 128 | 2 | 31091439 | |
| Pubmed | Acute effects of zinc and insulin on arcuate anorexigenic proopiomelanocortin neurons. | 8.02e-05 | 4 | 128 | 2 | 30521677 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 22696217 | ||
| Pubmed | Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. | 8.02e-05 | 4 | 128 | 2 | 21471202 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 33771873 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 23395167 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 21460216 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 32917787 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 17002572 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 30361437 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 15064719 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 32173907 | ||
| Pubmed | Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. | 8.02e-05 | 4 | 128 | 2 | 11433302 | |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 11756244 | ||
| Cytoband | 4p14 | 2.24e-04 | 42 | 128 | 3 | 4p14 | |
| Cytoband | 7q22.1 | 2.93e-04 | 113 | 128 | 4 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 3.88e-04 | 219 | 128 | 5 | chr7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 8.90e-04 | 67 | 128 | 3 | chr4p14 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.09e-07 | 12 | 84 | 4 | 756 | |
| GeneFamily | EF-hand domain containing | 5.46e-04 | 219 | 84 | 6 | 863 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.44e-04 | 40 | 84 | 3 | 321 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 9.37e-04 | 10 | 84 | 2 | 830 | |
| GeneFamily | Low density lipoprotein receptors | 1.61e-03 | 13 | 84 | 2 | 634 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 198 | 127 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-06 | 199 | 127 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.44e-06 | 170 | 127 | 6 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.44e-06 | 170 | 127 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 172 | 127 | 6 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.27e-05 | 179 | 127 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 181 | 127 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 181 | 127 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 182 | 127 | 6 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 182 | 127 | 6 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 187 | 127 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.62e-05 | 187 | 127 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.72e-05 | 189 | 127 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 191 | 127 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.88e-05 | 192 | 127 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.94e-05 | 193 | 127 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-05 | 195 | 127 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.05e-05 | 195 | 127 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.05e-05 | 195 | 127 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-05 | 196 | 127 | 6 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-05 | 196 | 127 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-05 | 196 | 127 | 6 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 127 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 127 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.59e-05 | 137 | 127 | 5 | 0bb5cccc31e7c44d44a2db3f59b68f9a81503151 | |
| ToppCell | TCGA-Uvea|World / Sample_Type by Project: Shred V9 | 5.27e-05 | 141 | 127 | 5 | 015451a83087f2705d3315ebc8f23797c6f10ed6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.75e-05 | 153 | 127 | 5 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5_FEZF2_DYRK2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.58e-05 | 160 | 127 | 5 | e2504c6deba4949a3a716a9ca68755f787bc0ae0 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 1.08e-04 | 164 | 127 | 5 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 165 | 127 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 165 | 127 | 5 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 165 | 127 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 166 | 127 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 166 | 127 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 166 | 127 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.17e-04 | 167 | 127 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 167 | 127 | 5 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 168 | 127 | 5 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 168 | 127 | 5 | 3e09516e819cf140a6dbf8f85247d3f08aa35bb8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 168 | 127 | 5 | 4a2e08b047f7170ae4b95eac9b2b128e55beee4a | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.27e-04 | 170 | 127 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 174 | 127 | 5 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.42e-04 | 174 | 127 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 176 | 127 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 177 | 127 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 179 | 127 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 179 | 127 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 182 | 127 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.75e-04 | 182 | 127 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-04 | 182 | 127 | 5 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 183 | 127 | 5 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 183 | 127 | 5 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-04 | 184 | 127 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.84e-04 | 184 | 127 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-04 | 184 | 127 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.89e-04 | 185 | 127 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 185 | 127 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 185 | 127 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-04 | 186 | 127 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.98e-04 | 187 | 127 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 187 | 127 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.98e-04 | 187 | 127 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 188 | 127 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.03e-04 | 188 | 127 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.08e-04 | 189 | 127 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 189 | 127 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-04 | 190 | 127 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.19e-04 | 191 | 127 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.19e-04 | 191 | 127 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.19e-04 | 191 | 127 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.24e-04 | 192 | 127 | 5 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.24e-04 | 192 | 127 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 127 | 5 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 127 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.24e-04 | 192 | 127 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.24e-04 | 192 | 127 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-04 | 193 | 127 | 5 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-04 | 193 | 127 | 5 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.30e-04 | 193 | 127 | 5 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 194 | 127 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 194 | 127 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 194 | 127 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-04 | 195 | 127 | 5 | ed052c6d3dc104b02e34b645abfdee477af050c6 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 195 | 127 | 5 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-04 | 195 | 127 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | distal-Epithelial-Proximal_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 196 | 127 | 5 | c102b28d5d1d90b9f7024cb51114276354be26a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-04 | 196 | 127 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | distal-Epithelial-Proximal_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 196 | 127 | 5 | a543d4623096cb3f9170dbf7af52381e77aa435e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-04 | 196 | 127 | 5 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | distal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 196 | 127 | 5 | 7e1a565dd2da4f375cbce8842ba4fd6c22ac8375 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 196 | 127 | 5 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-04 | 197 | 127 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.52e-04 | 197 | 127 | 5 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 2.52e-04 | 197 | 127 | 5 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 197 | 127 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-04 | 197 | 127 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-04 | 197 | 127 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 197 | 127 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-04 | 197 | 127 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | 6.59e-06 | 180 | 124 | 8 | 3290_DN | |
| Drug | v 110 | 8.66e-06 | 8 | 124 | 3 | CID000198155 | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A | 1.18e-05 | 195 | 124 | 8 | 2740_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.27e-05 | 197 | 124 | 8 | 7425_DN | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 1.32e-05 | 198 | 124 | 8 | 123_UP | |
| Disease | Autosomal dominant osteopetrosis | 1.70e-05 | 2 | 122 | 2 | cv:C4272579 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.43e-05 | 14 | 122 | 3 | DOID:9743 (implicated_via_orthology) | |
| Disease | hippocampal CA4 volume | 2.50e-05 | 41 | 122 | 4 | EFO_0009396 | |
| Disease | alcohol dependence measurement | 8.06e-05 | 55 | 122 | 4 | EFO_0007835 | |
| Disease | Metastatic melanoma | 1.47e-03 | 54 | 122 | 3 | C0278883 | |
| Disease | early cardiac repolarization measurement | 1.49e-03 | 14 | 122 | 2 | EFO_0004885 | |
| Disease | 4-acetamidobutanoate measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0021003 | |
| Disease | Multiple congenital anomalies | 2.21e-03 | 17 | 122 | 2 | C0000772 | |
| Disease | exercise test | 3.07e-03 | 20 | 122 | 2 | EFO_0004328 | |
| Disease | osteoporosis (biomarker_via_orthology) | 3.71e-03 | 22 | 122 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | gestational diabetes | 4.05e-03 | 23 | 122 | 2 | EFO_0004593 | |
| Disease | reticulocyte count | MYO9B INSR ODAD4 PTDSS2 PLXNB2 USP10 SERPINB9 LRP5 AKAP10 ATP11A ATP5F1B | 4.10e-03 | 1045 | 122 | 11 | EFO_0007986 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYEDILLQMDFIHIA | 706 | O60347 | |
| YTFEVIGHLETMIDA | 276 | P40394 | |
| YHLVVLVDILMDLGA | 271 | P49682 | |
| HLERLYGMITDLFID | 666 | Q8IWZ6 | |
| KAEIVLLDHGLYQML | 331 | Q86TW2 | |
| LLDHGLYQMLTEEFR | 336 | Q86TW2 | |
| LVFEYMDHDLMGLLE | 811 | Q9NYV4 | |
| HDTIVLPYFIQFMEL | 131 | O43572 | |
| VIEDTMVYGHLLQDS | 736 | Q9H5V8 | |
| LGTMHLEVQYEAIEL | 231 | Q6PIY5 | |
| DYHLLKDLEEGIQML | 141 | Q14406 | |
| QVEILGGRYHDLLLM | 296 | Q8IYM0 | |
| LELTQSFIIPLEHYM | 421 | Q8NEG7 | |
| LYHEMIESGVINLKD | 246 | P06576 | |
| MFVEGFHDAILLYVL | 356 | P17342 | |
| DLREMHTILADYFLG | 751 | Q9ULI1 | |
| VYVEMLQILLPHFSD | 1081 | Q68CQ1 | |
| EAQLIYRHLLGVEAM | 726 | O43374 | |
| LMEALAHLHLIEYVG | 691 | Q04671 | |
| EAQLIYRHLLGVEAM | 726 | C9J798 | |
| EYLQVMHFDTLLDDG | 276 | O95340 | |
| VVIDNLLLGTMAYDH | 121 | Q8NH92 | |
| SFREYLEEIEQHLMG | 876 | Q6ZRS4 | |
| MHSVLLGGEEQRYLL | 246 | Q02846 | |
| VEFLIVHYEQIFGMD | 746 | Q9P107 | |
| ILGKNDIFGEMVHLY | 801 | Q9NS40 | |
| LEEFNDVYLVTHLMG | 96 | Q16539 | |
| HMYEKTIAEGENLLL | 4901 | Q03001 | |
| VIGYLEDQIMSLHAE | 526 | O15111 | |
| DDLLVYNGILAMVSH | 1521 | O60303 | |
| LEQLLYGNHTIGMED | 21 | Q9NYS0 | |
| LIQGHLDFVMDILVF | 881 | O75197 | |
| EERELFGLQFMHTYI | 296 | Q96DD0 | |
| EHLFRYMVGTLELLV | 236 | Q7Z465 | |
| SLLEDMVYRLLGHVF | 5116 | Q5CZC0 | |
| VFIEGLYDMHIQLQS | 596 | P51798 | |
| VLDHLVGEETMADYL | 226 | Q9BT17 | |
| GLEYLSQIDMILIHQ | 86 | Q9NRY7 | |
| TDIMHTLFLELLEQY | 1366 | O15031 | |
| VYVELLFLTIMAHDR | 106 | Q8NHC7 | |
| ALTLLMIHYRAGIED | 1086 | Q8NEN9 | |
| MIHYRAGIEDIETLE | 1091 | Q8NEN9 | |
| DYMHVALGLLEEKLQ | 91 | P11678 | |
| DEFQTGILIYEMLHL | 1591 | Q9H792 | |
| RTIIQGHLDYVMDIL | 866 | O75581 | |
| DMVELLDGYTHRVLA | 266 | Q96MU8 | |
| IVILLDYMFQDLHNL | 141 | Q7L985 | |
| VIFEMVHLKELGLYN | 121 | P06213 | |
| FAIEMLDGHLYLLLD | 541 | Q9ULB1 | |
| ADMAAYQLELHGIEL | 76 | P28065 | |
| LGYLEHVLVMEEISR | 106 | P26440 | |
| HDVIALYHRMGLEEL | 326 | Q495T6 | |
| DILLFHEVLEYMSRI | 2626 | Q8NCM8 | |
| LLEDYQFVHPTFLEM | 2711 | Q8NCM8 | |
| LLNSMEFVSLLLYDH | 1341 | A4FU69 | |
| QELFDQIMYHLDLIE | 66 | Q9HCM4 | |
| KIIRENEHLGFLYMI | 191 | Q9C0G6 | |
| NYVEHMLFLLIEEQA | 66 | Q05DH4 | |
| ISELYVFLVDQMHVA | 601 | Q5T0N1 | |
| EEGDHLTMLNIYEAF | 541 | Q9H5Z1 | |
| NDLHILYLVTPMFED | 646 | O75417 | |
| HLQLFTEYGRLAMEE | 216 | Q8NHH9 | |
| LIEQAAEMLYGLIHA | 71 | P67870 | |
| RAEEAMELYHIALFL | 366 | Q9P203 | |
| LGLSDMNLYDHELVF | 336 | Q13867 | |
| YIDSNHMVDIGDIIF | 266 | Q8IY85 | |
| LDTLYIMGLHDEFLD | 231 | O60476 | |
| RLADEHVLIGLYVNM | 401 | Q9Y4J8 | |
| MEFHYVAQADLELLT | 1 | Q9H2J1 | |
| YMLDIFHEVLGGTEQ | 131 | O00219 | |
| DSRDYLHLLIGLFEM | 821 | Q9H583 | |
| MHIVADLYAEVIGVL | 221 | Q5TBA9 | |
| IEILHMDTVQLGYLF | 2141 | A6NE01 | |
| ELSEEQISHYLMEFG | 146 | Q9NV23 | |
| ILLEIYGFMHDHLNE | 1251 | Q9NZJ4 | |
| YTLLIMGIFHNEDLK | 1826 | Q92736 | |
| LMDYSLLVGIHDVER | 271 | P48426 | |
| TLEHLNQMVGIEYIL | 56 | O75586 | |
| MLFDEYQGLSHLEAL | 291 | Q8IWE2 | |
| QLMGVSLHELEDYIH | 71 | Q5VWG9 | |
| NIVQEHLYIDIFDGM | 331 | Q15542 | |
| SLFGYMEDLQELTII | 16 | Q6NUP7 | |
| SDLVEYFTLEMLHLG | 381 | Q9H5Y7 | |
| EEFEHVGYLVILMNI | 611 | Q4G0N8 | |
| DEEILSKYQLGMLHF | 176 | Q9BSW7 | |
| QHVTELELGMYALLG | 841 | Q24JP5 | |
| LESYLLHLEEMGVSE | 256 | Q16647 | |
| LETFMQGDYLLDELV | 346 | Q9UGC7 | |
| DHLSSLIIVMLYDFQ | 121 | Q8NE18 | |
| VEDLIMTGINYLDTH | 221 | Q96NG3 | |
| IMDYSLLVGIHDVDR | 276 | P78356 | |
| SVMFEFLEYSLEHQL | 221 | Q9BVG9 | |
| GRLHYLMQEDELVEL | 1051 | Q8TF17 | |
| LVHVEIYILAVMAFD | 106 | Q8NGP6 | |
| ENIDTYLIHMAIEIL | 1341 | Q14191 | |
| MLDVLEQFLTYHGHL | 2071 | Q6ZRS2 | |
| IHFFLALYLANDMEE | 246 | A6NHP3 | |
| YHVLDMIELGIENFV | 111 | Q9H7B2 | |
| YHIKIDGVEDMLLEL | 96 | P56279 | |
| LEEYHLGIGITFIDM | 471 | Q96P48 | |
| EFYLMQIVEIHTFVG | 336 | Q9UQC9 | |
| LYSLMEQHVGIDVLK | 931 | P98196 | |
| TDIQPDIFSYLLHIM | 66 | P24278 | |
| DFLHIAIQIAAGMEY | 591 | Q01973 | |
| FLHYAAAEGQIELME | 66 | O75762 | |
| EDYDMESVLRHLGIV | 276 | P50453 | |
| EHLYQQGMLSVAEEL | 126 | Q96G75 | |
| VENVGMLLVHLASYE | 611 | Q8NE28 | |
| YLEGMEEASIFVHVA | 866 | O75038 | |
| IHFFLALYLANDMEE | 206 | A6NNV3 | |
| IHFFLALYLANDMEE | 246 | P0DV79 | |
| IHFFLALYLANDMEE | 246 | A0A494C086 | |
| IHFFLALYLANDMEE | 246 | Q495Y8 | |
| IHFFLALYLANDMEE | 246 | A6NIY4 | |
| IHFFLALYLANDMEE | 246 | P0CI01 | |
| MKQVEELYHSLLELG | 1066 | Q13813 | |
| VEFDNLYLDMNGIIH | 46 | Q9H0D6 | |
| RGQILTHIFEMYEEI | 336 | Q8IZ13 | |
| VETLLHEMIHAYLFV | 106 | Q9H040 | |
| GIYVHATLELFALMV | 136 | Q9ULQ1 | |
| QMEDGHTLFDYEVRL | 51 | Q96T88 | |
| DVMLENYRHLVFLGI | 31 | Q03938 | |
| FQTMYEHLGELLTVL | 186 | Q2M389 | |
| EYLGFILNGLHEEML | 526 | Q14694 | |
| IHFFLALYLANDMEE | 206 | A6NJR5 | |
| MELLLNHSVYVGDAL | 86 | Q9UL62 | |
| LVRDMLHFYAEQGDV | 636 | Q96S15 | |
| NLYTFLLALMDDVHL | 516 | Q8TDI7 | |
| HYMVLEYVDLGDLKQ | 871 | Q13308 | |
| LGIRMLDVLEYIHEN | 146 | Q86Y07 | |
| TEVAYLIHEGMFISD | 506 | Q9P1Q0 | |
| TLQEHADLMYGDIEL | 571 | Q8N8K9 | |
| LEKLLEHVEMHGLYT | 1716 | Q13459 |